SCHEMBL23472209

SCHEMBL23472209

CCCCNc1nc(N)ccc1OCc1noc(-c2ccccc2)n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMPD1 P17405 2/20 0.48
▸ MAPT P10636 2/20 0.44
▸ SMN1; SMN2 Q16637 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ PKM P14618 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ CYP1A2 P05177 3/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ BCHE P06276 1/20 0.43
▸ ACHE P22303 1/20 0.43
▸ ERBB2 P04626 1/20 0.43
▸ EPHA2 P29317 1/20 0.43
▸ KDR P35968 1/20 0.43
▸ EPHB4 P54760 1/20 0.43
▸ TDP1 Q9NUW8 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13195062 0.88 CYP1A2 (0.46) SMPD1MAPTSMN1; SMN2KDM4ENPC1
SCHEMBL23472412 0.74 MCHR1 (0.48) CYP1A2CYP2D6L3MBTL1TLR8TLR7
SCHEMBL23472208 0.74 KDM4E (0.49) MAPTSMN1; SMN2KDM4ENPC1ALDH1A1
SCHEMBL23472527 0.73 TLR8 (0.58) CYP1A2CYP2D6TLR8TLR7
SCHEMBL23472525 0.73 CYP1A2 (0.44) CYP1A2CYP2D6TLR8TLR7
SCHEMBL13195146 0.69 RAB9A (0.52) MAPTSMN1; SMN2KDM4ENPC1HPGD
SCHEMBL23472693 0.69 TLR8 (0.46) CYP1A2CYP2D6KDRL3MBTL1TLR8
SCHEMBL23472233 0.69 CYP1A2 (0.46) CYP1A2CYP2D6L3MBTL1TLR8TLR7
SCHEMBL13195753 0.68 TLR8 (0.45) CYP1A2CYP2D6L3MBTL1TLR8TLR7
SCHEMBL13195730 0.68 CYP1A2 (0.59) CYP1A2CYP2D6L3MBTL1TLR8TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3590928-B1 PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF VIRAL INFECTIONS JANSSEN SCIENCES IRELAND UNLIMITED CO (IE) 2021-06-09 — — EP disclosed
Send feedback